A Comparison of Fluconazole and Amphotericin B in the Treatment of Fungal Infections

Phase 3

Completed

• Conditions: Mycoses; HIV Infections

• Registration Number: NCT00002277
• Lead Sponsor: Pfizer

Brief Summary

To compare the safety, tolerance and efficacy of fluconazole and amphotericin B as treatment for biopsy proven fungal infections in major organs, disseminated infection, suspected fungal infection and fungemia in adult neutropenic and non-neutropenic patients without AIDS, AIDS related complex (ARC), or extensive burns. HIV seropositive patients are allowed only if they also have a malignancy.

Detailed Description

Not available

Study Timeline

• Status Verified: 1993-12
• Study First Submitted: 1999-11-02
• Study First Submitted QC: 2001-08-30
• Study First Posted: 2001-08-31
• Last Update Submitted: 2005-06-23
• Last Update Posted: 2005-06-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Trial Locations

Locations (3)

Dr Layne Gentry; 🇺🇸 Houston, Texas, United States

Dr Temple Williams; 🇺🇸 Houston, Texas, United States

M D Anderson Cancer Ctr; 🇺🇸 Houston, Texas, United States